These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 18516803

  • 1. Aliskiren: new drug. Arterial hypertension: no evidence of clinical efficacy.
    Prescrire Int; 2008 Apr; 17(94):47-50. PubMed ID: 18516803
    [Abstract] [Full Text] [Related]

  • 2. Aliskiren: an oral renin inhibitor for the treatment of hypertension.
    Lam S, Choy M.
    Cardiol Rev; 2007 Apr; 15(6):316-23. PubMed ID: 18090068
    [Abstract] [Full Text] [Related]

  • 3. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
    Pool JL, Schmieder RE, Azizi M, Aldigier JC, Januszewicz A, Zidek W, Chiang Y, Satlin A.
    Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
    [Abstract] [Full Text] [Related]

  • 4. Aliskiren: an oral direct renin inhibitor for the treatment of hypertension.
    Sanoski CA.
    Pharmacotherapy; 2009 Feb; 29(2):193-212. PubMed ID: 19170589
    [Abstract] [Full Text] [Related]

  • 5. Aliskiren: renin inhibitor for hypertension management.
    Cheng JW.
    Clin Ther; 2008 Jan; 30(1):31-47. PubMed ID: 18343241
    [Abstract] [Full Text] [Related]

  • 6. Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide.
    Schmieder RE, Philipp T, Guerediaga J, Gorostidi M, Smith B, Weissbach N, Maboudian M, Botha J, van Ingen H.
    Circulation; 2009 Jan 27; 119(3):417-25. PubMed ID: 19139391
    [Abstract] [Full Text] [Related]

  • 7. Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension.
    Nussberger J, Gradman AH, Schmieder RE, Lins RL, Chiang Y, Prescott MF.
    Int J Clin Pract; 2007 Sep 27; 61(9):1461-8. PubMed ID: 17590217
    [Abstract] [Full Text] [Related]

  • 8. The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.
    Gradman AH, Traub D.
    Rev Cardiovasc Med; 2007 Sep 27; 8 Suppl 2():S22-30. PubMed ID: 17401313
    [Abstract] [Full Text] [Related]

  • 9. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
    Dietz R, Dechend R, Yu CM, Bheda M, Ford J, Prescott MF, Keefe DL.
    J Renin Angiotensin Aldosterone Syst; 2008 Sep 27; 9(3):163-75. PubMed ID: 18957387
    [Abstract] [Full Text] [Related]

  • 10. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
    Vaidyanathan S, Valencia J, Kemp C, Zhao C, Yeh CM, Bizot MN, Denouel J, Dieterich HA, Dole WP.
    Int J Clin Pract; 2006 Nov 27; 60(11):1343-56. PubMed ID: 17073832
    [Abstract] [Full Text] [Related]

  • 11. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.
    Dalla Vestra M, Simioni N, Masiero A.
    Minerva Endocrinol; 2009 Dec 27; 34(4):333-8. PubMed ID: 20046162
    [Abstract] [Full Text] [Related]

  • 12. Aliskiren for renin inhibition: a new class of antihypertensives.
    Van Tassell BW, Munger MA.
    Ann Pharmacother; 2007 Mar 27; 41(3):456-64. PubMed ID: 17341529
    [Abstract] [Full Text] [Related]

  • 13. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
    Villamil A, Chrysant SG, Calhoun D, Schober B, Hsu H, Matrisciano-Dimichino L, Zhang J.
    J Hypertens; 2007 Jan 27; 25(1):217-26. PubMed ID: 17143194
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the dose--response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension.
    Puig JG, Schunkert H, Taylor AA, Boye S, Jin J, Keefe DL.
    Clin Ther; 2009 Dec 27; 31(12):2839-50. PubMed ID: 20110023
    [Abstract] [Full Text] [Related]

  • 15. Long-term safety, tolerability, and antihypertensive efficacy of aliskiren, an oral direct renin inhibitor, in Japanese patients with hypertension.
    Kushiro T, Itakura H, Abo Y, Gotou H, Terao S, Keefe DL.
    Hypertens Res; 2009 Mar 27; 32(3):169-75. PubMed ID: 19262478
    [Abstract] [Full Text] [Related]

  • 16. Aliskiren.
    Brown MJ.
    Circulation; 2008 Aug 12; 118(7):773-84. PubMed ID: 18695203
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.
    Uresin Y, Taylor AA, Kilo C, Tschöpe D, Santonastaso M, Ibram G, Fang H, Satlin A.
    J Renin Angiotensin Aldosterone Syst; 2007 Dec 12; 8(4):190-8. PubMed ID: 18205098
    [Abstract] [Full Text] [Related]

  • 18. Aliskiren in the management of hypertension.
    Barrios V, Escobar C.
    Am J Cardiovasc Drugs; 2010 Dec 12; 10(6):349-58. PubMed ID: 21090828
    [Abstract] [Full Text] [Related]

  • 19. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K.
    Vnitr Lek; 2007 Apr 12; 53(4):364-70. PubMed ID: 17578167
    [Abstract] [Full Text] [Related]

  • 20. Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension.
    Riccioni G, Vitulano N, D'Orazio N, Bellocci F.
    Adv Ther; 2009 Jul 12; 26(7):700-10. PubMed ID: 19649581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.